Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NEOG vs WGS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NEOG Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

NEOG Overall Winner 6-Pillar Tally: NEOG 5 – 1 WGS Matrix Metrics: NEOG 9 – 1 WGS

As of Nov 16, 2026, Neogen Corp (NEOG) is the stronger overall head-to-head candidate over GeneDx Holdings Corp. (WGS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NEOG carries a Unified Composite Score of 43.0/100 (HOLD) at $10.88 (36.3x Forward P/E, -0.8% operating margin), whereas WGS carries 49.5/100 (HOLD) at $51.02 (40.6x Forward P/E, -13.7% operating margin).

  • Composite vs. Pillar Nuance: While WGS currently prints a higher short-term Unified Composite Score (49.5/100 HOLD vs. NEOG 43.0/100 HOLD), NEOG captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (-0.8% vs. -13.7% operating margin) and revenue trajectory (+6.5% vs. +5.4% YoY).
  • Technical & Structure Timing Caution: NEOG trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 36.3); meanwhile WGS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NEOG vs WGS
NEOG NASDAQ Head-to-Head Winner
Neogen Corp
In Vitro & In Vivo Diagnostic Substances
$10.88
-3.12% 1D
Market Cap $2.5B
TTM Revenue $884M
Forward P/E 36.3x
Beta / 30D Vol 1.41β · 40% Vol
Unified Composite Score
43.0 / 100 HOLD
Tech 23.0 Fund 46.0 Flow 61.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 36
RSI-14: 36.3 · SMA20: $11.85 · SMA50: $12.22
WGS NASDAQ
GeneDx Holdings Corp. Class A Common Stock
Services-Health Services
$51.02
-2.58% 1D
Market Cap $1.6B
TTM Revenue $461M
Forward P/E 40.6x
Beta / 30D Vol 1.74β · 111% Vol
Unified Composite Score
49.5 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 70.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.3%), weak momentum, RSI 35
RSI-14: 34.8 · SMA20: $62.47 · SMA50: $73.13

6-Pillar Scorecard Institutional Category Breakdown (NEOG 5 – 1 WGS)

Columns: Metric · NEOG · WGS
1. Valuation Multiples NEOG
Forward P/E 36.3x 40.6x
Trailing P/E 16.0x 38.8x
PEG Ratio 0.66x N/M
EV / Revenue 3.5x 3.7x
2. Growth & Scale NEOG
Revenue Growth (YoY) +6.5% +5.4%
Earnings Growth (YoY) -85.6% +0.0%
TTM Revenue (USD) $884M $461M
Market Cap $2.5B $1.6B
3. Profitability & Quality NEOG
Gross Margin 47.4% 68.8%
Operating Margin -0.8% -13.7%
Net Profit Margin -6.3% -24.1%
Return on Equity (ROE) -2.7% -41.4%
4. Balance Sheet & Cash Flow NEOG
Cash Generation (TTM) $50M -$101M
Cash Flow Margin 5.6% -22.0%
Net Cash / Leverage $602M Net Debt (0.37x D/E) $119M Net Debt (0.88x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning NEOG
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 46.0% (25th %ile) 102.3% (21st %ile)
Put/Call OI Skew N/A 7.82x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat WGS
OpEx & R&D Intensity 48.2% of Rev ($426M) 82.5% of Rev ($380M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Diagnostics & Research Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NEOG (9) vs WGS (1)
Institutional Metric NEOG WGS Criterion Row Edge
Market Capitalization
Scale
$2.5B $1.6B Larger Scale NEOG
Trailing P/E Ratio
Valuation
16.0x 38.8x Lower Multiple NEOG
Forward P/E Ratio
Valuation
36.3x 40.6x Lower Multiple NEOG
Revenue Growth (YoY)
Growth
+6.5% +5.4% Higher Growth NEOG
Operating Margin (TTM)
Profitability
-0.8% -13.7% Higher Margin NEOG
Net Profit Margin
Profitability
-6.3% -24.1% Higher Margin NEOG
Return on Equity (ROE)
Capital Efficiency
-2.7% -41.4% Higher ROE NEOG
52-Week Range Position
Momentum
62% ($5–$14) 14% ($32–$171) Stronger Trend NEOG
Beta / 30D Volatility
Risk Regime
1.41β · 40% Vol 1.74β · 111% Vol Lower Realized Risk NEOG
Unified Institutional Score
Composite Signal
43.0 / 100 (HOLD) 49.5 / 100 (HOLD) Higher Composite WGS
Trailing 12M Revenue (USD)
Operating Scale
$884M $461M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
47.4% 68.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.66x PEG · 3.5x EV/Rev N/M PEG · 3.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$50M ($602M Net Debt (0.37x D/E)) -$101M ($119M Net Debt (0.88x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NEOG +11.92 pp
NEOG: -7.87% · WGS: -19.79%
3M Horizon NEOG +27.21 pp
NEOG: -5.96% · WGS: -33.17%
6M Horizon NEOG +7.59 pp
NEOG: +27.1% · WGS: +19.51%
1Y Horizon NEOG +131.66 pp
NEOG: +70.8% · WGS: -60.86%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period NEOG Revenue WGS Revenue NEOG Op. Margin WGS Op. Margin Margin Leader
FY2019 $410M $200M 16.4% -15.5% NEOG
FY2020 $420M $180M 16.1% -134.9% NEOG
FY2021 $470M $210M 15.8% -210.3% NEOG
FY2022 $530M $230M 11.1% -284.5% NEOG
FY2023 $820M $200M 4.6% -89.2% NEOG
FY2024 $920M $310M 6.3% -7.6% NEOG
FY2025 $890M $430M -118.6% -3.1% WGS
FY2026 $870M N/A -2.5% N/A NEOG

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NEOG CONSOLIDATION
39d in phase · OBV NEUTRAL
Current IV 46.0%
IV Percentile 25th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact NEOG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
WGS BREAKDOWN
96d in phase · OBV DISTRIBUTION
Current IV 102.3%
IV Percentile 21st %ile
Put/Call OI Skew 7.82x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact WGS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NEOG Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $2.5B market capitalization and -0.8% operating margin.
OpEx & R&D Reinvestment 48.2% of Rev ($426M)
90D Engineering Disclosures 0 Published
WGS Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $1.6B market capitalization and -13.7% operating margin.
OpEx & R&D Reinvestment 82.5% of Rev ($380M)
90D Engineering Disclosures 0 Published

Investor FAQ NEOG vs WGS Key Questions & Quantitative Answers

As of Nov 16, 2026, Neogen Corp (NEOG) is the stronger overall head-to-head candidate over GeneDx Holdings Corp. (WGS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NEOG carries a Unified Composite Score of 43.0/100 (HOLD) at $10.88 (36.3x Forward P/E, -0.8% operating margin), whereas WGS carries 49.5/100 (HOLD) at $51.02 (40.6x Forward P/E, -13.7% operating margin). Composite vs. Pillar Nuance: While WGS currently prints a higher short-term Unified Composite Score (49.5/100 HOLD vs. NEOG 43.0/100 HOLD), NEOG captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (-0.8% vs. -13.7% operating margin) and revenue trajectory (+6.5% vs. +5.4% YoY). Technical & Structure Timing Caution: NEOG trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 36.3); meanwhile WGS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NEOG leads the Growth & Scale pillar: NEOG posts +6.5% YoY revenue growth and -85.6% YoY earnings growth on $884M TTM revenue (47.4% gross margin, -0.8% operating margin), compared with WGS at +5.4% YoY revenue growth and +0.0% YoY earnings growth on $461M TTM revenue (68.8% gross margin, -13.7% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), NEOG cumulative revenue shifted +112.2% while WGS shifted +115.0%. In operating R&D and SG&A reinvestment, NEOG deploys 48.2% of Rev ($426M) (0 90-day corporate R&D disclosures) versus 82.5% of Rev ($380M) (0 disclosures) for WGS.

NEOG screens cheaper on headline valuation multiples. NEOG trades at 36.3x Forward P/E, 16.0x Trailing P/E, 0.66x PEG, and 3.5x EV/Revenue (5.6% FCF margin), whereas WGS trades at 40.6x Forward P/E, 38.8x Trailing P/E, N/M PEG, and 3.7x EV/Revenue (-22.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NEOG (-2.7% ROE) versus WGS (-41.4% ROE) capital efficiency.

In options market volatility and institutional positioning, NEOG carries 46.0% implied volatility (25th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.41β · 40% Vol realized risk). By comparison, WGS carries 102.3% implied volatility (21st %ile, Compressed (<25th %ile)), a 7.82x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.74β · 111% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.